Research Catalog

Nonprescription drugs considerations regarding a behind-the-counter drug class : report to congressional requesters.

Title
Nonprescription drugs [electronic resource] : considerations regarding a behind-the-counter drug class : report to congressional requesters.
Author
United States. Government Accountability Office.
Publication
[Washington, D.C.] : U.S. Govt. Accountability Office, [2009]

Available Online

http://purl.access.gpo.gov/GPO/LPS113194

Details

Description
ii, 54 p. : digital, PDF file.
Summary
In the United States, most nonprescription drugs are available over-the-counter (OTC) in pharmacies and other stores. Experts have suggested that drug availability could be increased by establishing an additional class of nonprescription drugs that would be held behind the counter (BTC) but would require the intervention of a pharmacist before being dispensed; a similar class of drugs exists in many other countries. Although the Food and Drug Administration (FDA) has not developed a detailed proposal for a BTC drug class, it held a public meeting in 2007 to explore the public health implications of BTC drug availability. GAO was asked to update its 1995 report, Nonprescription Drugs: Value of a Pharmacist-Controlled Class Has Yet to Be Demonstrated (GAO/PEMD-95-12). Specifically, GAO is reporting on (1) arguments supporting and opposing a U.S. BTC drug class, (2) changes in drug availability in five countries since 1995 and the impact of restricted nonprescription classes on availability, and (3) issues important to the establishment of a BTC drug class. GAO reviewed documents and consulted with pharmaceutical experts. To examine drug availability across countries, GAO studied five countries it had reported on in 1995 (Australia, Italy, the Netherlands, the United Kingdom, and the United States) and determined how 86 drugs available in all five countries were classified in each country.
Alternative Title
  • Nonprescription drugs : considerations regarding a behind the counter drug class
  • Considerations regarding a behind-the-counter drug class
  • Behind-the-counter drug class
Subjects
Note
  • Title from title screen (viewed on Mar. 24, 2009).
  • "February 2009."
  • "GAO-09-245."
Bibliography (note)
  • Includes bibliographical references.
System Details (note)
  • System requirements: Adobe Acrobat Reader.
  • Mode of access: World Wide Web from GAO web site. Address as of 3/24/09: http://www.gao.gov/new.items/d09245.pdf ; current access available via PURL.
Call Number
GPO Internet GA 1.13:GAO-09-245
OCLC
316854515
Author
United States. Government Accountability Office.
Title
Nonprescription drugs [electronic resource] : considerations regarding a behind-the-counter drug class : report to congressional requesters.
Imprint
[Washington, D.C.] : U.S. Govt. Accountability Office, [2009]
System Details
System requirements: Adobe Acrobat Reader.
Mode of access: World Wide Web from GAO web site. Address as of 3/24/09: http://www.gao.gov/new.items/d09245.pdf ; current access available via PURL.
Bibliography
Includes bibliographical references.
Connect to:
http://purl.access.gpo.gov/GPO/LPS113194
Running Title
Behind-the-counter drug class
Gpo Item No.
0546-D (online)
Sudoc No.
GA 1.13:GAO-09-245
Research Call Number
GPO Internet GA 1.13:GAO-09-245
View in Legacy Catalog